Axon Enterprise Stock Forecast, Price & News

Axon Enterprise (NASDAQ:AXON) Frequently Asked Questions

Is Axon Enterprise a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Axon Enterprise stock.
View analyst ratings for Axon Enterprise or view top-rated stocks.

What stocks does MarketBeat like better than Axon Enterprise?

Wall Street analysts have given Axon Enterprise a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Axon Enterprise wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Axon Enterprise's next earnings date?

Axon Enterprise is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Axon Enterprise.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) released its quarterly earnings results on Thursday, August, 5th. The biotechnology company reported ($0.72) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by $0.63. The biotechnology company earned $218.80 million during the quarter, compared to the consensus estimate of $173.07 million. Axon Enterprise had a negative net margin of 8.69% and a negative trailing twelve-month return on equity of 7.35%.
View Axon Enterprise's earnings history.

How has Axon Enterprise's stock price been impacted by Coronavirus?

Axon Enterprise's stock was trading at $2.82 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AXON shares have increased by 6,209.9% and is now trading at $177.94.
View which stocks have been most impacted by COVID-19.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise updated its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $825 million-$850 million, compared to the consensus revenue estimate of $806.32 million.

What price target have analysts set for AXON?

6 Wall Street analysts have issued 1 year price objectives for Axon Enterprise's stock. Their forecasts range from $170.00 to $250.00. On average, they anticipate Axon Enterprise's stock price to reach $204.50 in the next year. This suggests a possible upside of 14.9% from the stock's current price.
View analysts' price targets for Axon Enterprise or view top-rated stocks among Wall Street analysts.

Who are Axon Enterprise's key executives?

Axon Enterprise's management team includes the following people:

• Patrick W. Smith, Chief Executive Officer & Director (LinkedIn Profile)
• Luke S. Larson, President (LinkedIn Profile)
• Josh Goldman, Senior Vice President-Operations
• Jawad A. Ahsan, Chief Financial Officer (LinkedIn Profile)
• Jenner Holden, Chief Information Security Officer

Who are some of Axon Enterprise's key competitors?

Some companies that are related to Axon Enterprise include Microsoft (MSFT), Oracle (ORCL), ServiceNow (NOW), VMware (VMW), Fortinet (FTNT), C3.ai (AI), Qualys (QLYS), Commvault Systems (CVLT), Progress Software (PRGS) and FalconStor Software (FALC).
View all of AXON's competitors.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), (CGC), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering (IPO) on Thursday, June 11th 2015. The company issued 17,900,000 shares at $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by a number of retail and institutional investors. Top institutional investors include Louisiana State Employees Retirement System (0.03%), State of Alaska Department of Revenue (0.02%), Pacer Advisors Inc. (0.02%), Wedbush Securities Inc. (0.01%), Juncture Wealth Strategies LLC (0.01%) and Beese Fulmer Investment Management Inc. (0.01%). Company insiders that own Axon Enterprise stock include Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, Matthew R Mcbrady and Patrick W Smith.
View institutional ownership trends for Axon Enterprise.

Which major investors are buying Axon Enterprise stock?

AXON stock was purchased by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System, State of Alaska Department of Revenue, Pacer Advisors Inc., Wedbush Securities Inc., Beese Fulmer Investment Management Inc., Gofen & Glossberg LLC IL, IBM Retirement Fund, and Insight Folios Inc.
View insider buying and selling activity for Axon Enterprise or or view top insider-buying stocks.

How do I buy shares of Axon Enterprise?

Shares of AXON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $177.94.

How much money does Axon Enterprise make?

Axon Enterprise has a market capitalization of $11.69 billion and generates $681 million in revenue each year. The biotechnology company earns $-1.72 million in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does Axon Enterprise have?

Axon Enterprise employs 1,710 workers across the globe.

What is Axon Enterprise's official website?

The official website for Axon Enterprise is www.axovant.com.

Where are Axon Enterprise's headquarters?

Axon Enterprise is headquartered at 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company can be reached via phone at (480) 991-0797 or via email at [email protected].